4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide

C183H134F4N34O34 — CID 157369318

IUPAC4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide
SMILESCC(=O)c1ccc(C(=O)NCc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.N#Cc1ccc(/C=C/C(=O)Nc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.N#Cc1ccc(C(=O)NCc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.O=C(/C=C/C=C/c1ccccc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(F)cc1)NCc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccccc1)NCc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(CCc1ccc(O)cc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1
InChIInChI=1S/C24H18N4O4.C23H15F3N4O4.C23H17FN4O4.C23H15N5O4.C23H18N4O5.C23H18N4O4.C22H15N5O4.C22H18N4O5/c29-23(9-5-4-8-17-6-2-1-3-7-17)25-19-12-10-18(11-13-19)24-26-21-15-14-20(28(31)32)16-22(21)27(24)30;24-23(25,26)16-6-1-14(2-7-16)3-12-21(31)27-17-8-4-15(5-9-17)22-28-19-11-10-18(30(33)34)13-20(19)29(22)32;24-18-8-3-15(4-9-18)5-12-22(29)25-14-16-1-6-17(7-2-16)23-26-20-11-10-19(28(31)32)13-21(20)27(23)30;24-14-16-3-1-15(2-4-16)5-12-22(29)25-18-8-6-17(7-9-18)23-26-20-11-10-19(28(31)32)13-21(20)27(23)30;1-14(28)16-6-8-18(9-7-16)23(29)24-13-15-2-4-17(5-3-15)22-25-20-11-10-19(27(31)32)12-21(20)26(22)30;28-22(13-8-16-4-2-1-3-5-16)24-15-17-6-9-18(10-7-17)23-25-20-12-11-19(27(30)31)14-21(20)26(23)29;23-12-14-1-7-17(8-2-14)22(28)24-13-15-3-5-16(6-4-15)21-25-19-10-9-18(27(30)31)11-20(19)26(21)29;27-18-9-1-14(2-10-18)3-12-21(28)23-16-6-4-15(5-7-16)22-24-19-11-8-17(26(30)31)13-20(19)25(22)29/h1-16,30H,(H,25,29);1-13,32H,(H,27,31);1-13,30H,14H2,(H,25,29);1-13,30H,(H,25,29);2-12,30H,13H2,1H3,(H,24,29);1-14,29H,15H2,(H,24,28);1-11,29H,13H2,(H,24,28);1-2,4-11,13,27,29H,3,12H2,(H,23,28)/b8-4+,9-5+;12-3+;2*12-5+;;13-8+;;
InChIKeyBJOIQBDREYSDKR-FXBWXIHKSA-N
MW3429.28 g/mol
LogP35.20
Rot. Bonds45

About 4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide

4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide (PubChem CID 157369318) has the molecular formula C183H134F4N34O34 and a molecular weight of 3429.28 g/mol. Its IUPAC name is 4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide.

Molecular Properties

Compound Name4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide
PubChem CID157369318
Molecular FormulaC183H134F4N34O34
Molecular Weight3429.28 g/mol
Exact Mass3426.97
IUPAC Name4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide
SMILESCC(=O)c1ccc(C(=O)NCc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.N#Cc1ccc(/C=C/C(=O)Nc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.N#Cc1ccc(C(=O)NCc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.O=C(/C=C/C=C/c1ccccc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(F)cc1)NCc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccccc1)NCc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(CCc1ccc(O)cc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1
InChIInChI=1S/C24H18N4O4.C23H15F3N4O4.C23H17FN4O4.C23H15N5O4.C23H18N4O5.C23H18N4O4.C22H15N5O4.C22H18N4O5/c29-23(9-5-4-8-17-6-2-1-3-7-17)25-19-12-10-18(11-13-19)24-26-21-15-14-20(28(31)32)16-22(21)27(24)30;24-23(25,26)16-6-1-14(2-7-16)3-12-21(31)27-17-8-4-15(5-9-17)22-28-19-11-10-18(30(33)34)13-20(19)29(22)32;24-18-8-3-15(4-9-18)5-12-22(29)25-14-16-1-6-17(7-2-16)23-26-20-11-10-19(28(31)32)13-21(20)27(23)30;24-14-16-3-1-15(2-4-16)5-12-22(29)25-18-8-6-17(7-9-18)23-26-20-11-10-19(28(31)32)13-21(20)27(23)30;1-14(28)16-6-8-18(9-7-16)23(29)24-13-15-2-4-17(5-3-15)22-25-20-11-10-19(27(31)32)12-21(20)26(22)30;28-22(13-8-16-4-2-1-3-5-16)24-15-17-6-9-18(10-7-17)23-25-20-12-11-19(27(30)31)14-21(20)26(23)29;23-12-14-1-7-17(8-2-14)22(28)24-13-15-3-5-16(6-4-15)21-25-19-10-9-18(27(30)31)11-20(19)26(21)29;27-18-9-1-14(2-10-18)3-12-21(28)23-16-6-4-15(5-7-16)22-24-19-11-8-17(26(30)31)13-20(19)25(22)29/h1-16,30H,(H,25,29);1-13,32H,(H,27,31);1-13,30H,14H2,(H,25,29);1-13,30H,(H,25,29);2-12,30H,13H2,1H3,(H,24,29);1-14,29H,15H2,(H,24,28);1-11,29H,13H2,(H,24,28);1-2,4-11,13,27,29H,3,12H2,(H,23,28)/b8-4+,9-5+;12-3+;2*12-5+;;13-8+;;
InChIKeyBJOIQBDREYSDKR-FXBWXIHKSA-N
XLogP35.20
TPSA967.20 Ų
H-Bond Donors17
H-Bond Acceptors52
Rotatable Bonds45
Heavy Atoms255
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003429.28
LogP ≤ 535.20
H-Bond Donors ≤ 517
H-Bond Acceptors ≤ 1052

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'N-hydroxyl_pyridine', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'}

Analyze 4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide?
The IUPAC name of 4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide (CID 157369318) is 4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide.
What is the SMILES notation for 4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide?
The canonical SMILES for 4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide is CC(=O)c1ccc(C(=O)NCc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.N#Cc1ccc(/C=C/C(=O)Nc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.N#Cc1ccc(C(=O)NCc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.O=C(/C=C/C=C/c1ccccc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(F)cc1)NCc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccccc1)NCc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(CCc1ccc(O)cc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.
What is the InChIKey of 4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide?
The InChIKey is BJOIQBDREYSDKR-FXBWXIHKSA-N. The full InChI is InChI=1S/C24H18N4O4.C23H15F3N4O4.C23H17FN4O4.C23H15N5O4.C23H18N4O5.C23H18N4O4.C22H15N5O4.C22H18N4O5/c29-23(9-5-4-8-17-6-2-1-3-7-17)25-19-12-10-18(11-13-19)24-26-21-15-14-20(28(31)32)16-22(21)27(24)30;24-23(25,26)16-6-1-14(2-7-16)3-12-21(31)27-17-8-4-15(5-9-17)22-28-19-11-10-18(30(33)34)13-20(19)29(22)32;24-18-8-3-15(4-9-18)5-12-22(29)25-14-16-1-6-17(7-2-16)23-26-20-11-10-19(28(31)32)13-21(20)27(23)30;24-14-16-3-1-15(2-4-16)5-12-22(29)25-18-8-6-17(7-9-18)23-26-20-11-10-19(28(31)32)13-21(20)27(23)30;1-14(28)16-6-8-18(9-7-16)23(29)24-13-15-2-4-17(5-3-15)22-25-20-11-10-19(27(31)32)12-21(20)26(22)30;28-22(13-8-16-4-2-1-3-5-16)24-15-17-6-9-18(10-7-17)23-25-20-12-11-19(27(30)31)14-21(20)26(23)29;23-12-14-1-7-17(8-2-14)22(28)24-13-15-3-5-16(6-4-15)21-25-19-10-9-18(27(30)31)11-20(19)26(21)29;27-18-9-1-14(2-10-18)3-12-21(28)23-16-6-4-15(5-7-16)22-24-19-11-8-17(26(30)31)13-20(19)25(22)29/h1-16,30H,(H,25,29);1-13,32H,(H,27,31);1-13,30H,14H2,(H,25,29);1-13,30H,(H,25,29);2-12,30H,13H2,1H3,(H,24,29);1-14,29H,15H2,(H,24,28);1-11,29H,13H2,(H,24,28);1-2,4-11,13,27,29H,3,12H2,(H,23,28)/b8-4+,9-5+;12-3+;2*12-5+;;13-8+;;.
What are the key properties of 4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide?
4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide has a molecular weight of 3429.28 g/mol, XLogP of 35.20, 45 rotatable bonds, 17 hydrogen bond donors, and 52 hydrogen bond acceptors.
Where does this data come from?
All data for 4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide is sourced from PubChem (CID 157369318), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).